Corgenix Medical Corp.
| OTC Markets: CONX
Corgenix Medical Corp. engages in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world's only non-blood-based test for determining the effectiveness of aspirin. The company's products are used in clinical laboratories for the diagnosis and the monitoring of three important sectors of health care: autoimmune disease in which an individual creates antibodies to one's self, for example, systemic lupus erythematosus and rheumatoid arthritis, vascular disease associated with certain types of thrombosis or clot formation, for example, antiphospholipid syndrome, deep vein thrombosis, stroke and coronary occlusion and liver diseases fibrosis and cirrhosis. It is developing products for diagnostic testing areas used in Microplate Enzyme Linked ImmunoSorbent, Lateral Flow Immunoassay and Immmunoturbidimetry. The company was founded by Luis R. Lopez in 1990 and is headquartered in Broomfield, CO.